1. Home
  2. BLTE vs ARDT Comparison

BLTE vs ARDT Comparison

Compare BLTE & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • ARDT
  • Stock Information
  • Founded
  • BLTE 2018
  • ARDT 2001
  • Country
  • BLTE United States
  • ARDT United States
  • Employees
  • BLTE N/A
  • ARDT N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • ARDT
  • Sector
  • BLTE Health Care
  • ARDT
  • Exchange
  • BLTE Nasdaq
  • ARDT NYSE
  • Market Cap
  • BLTE 2.1B
  • ARDT 2.0B
  • IPO Year
  • BLTE 2022
  • ARDT 2024
  • Fundamental
  • Price
  • BLTE $58.91
  • ARDT $14.27
  • Analyst Decision
  • BLTE Strong Buy
  • ARDT Buy
  • Analyst Count
  • BLTE 4
  • ARDT 11
  • Target Price
  • BLTE $96.33
  • ARDT $21.55
  • AVG Volume (30 Days)
  • BLTE 46.8K
  • ARDT 302.3K
  • Earning Date
  • BLTE 03-10-2025
  • ARDT 02-22-2025
  • Dividend Yield
  • BLTE N/A
  • ARDT N/A
  • EPS Growth
  • BLTE N/A
  • ARDT N/A
  • EPS
  • BLTE N/A
  • ARDT 0.64
  • Revenue
  • BLTE N/A
  • ARDT $5,705,817,000.00
  • Revenue This Year
  • BLTE N/A
  • ARDT $10.20
  • Revenue Next Year
  • BLTE N/A
  • ARDT $7.83
  • P/E Ratio
  • BLTE N/A
  • ARDT $22.56
  • Revenue Growth
  • BLTE N/A
  • ARDT 11.23
  • 52 Week Low
  • BLTE $31.01
  • ARDT $13.63
  • 52 Week High
  • BLTE $86.53
  • ARDT $20.72
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 46.75
  • ARDT N/A
  • Support Level
  • BLTE $52.03
  • ARDT N/A
  • Resistance Level
  • BLTE $61.66
  • ARDT N/A
  • Average True Range (ATR)
  • BLTE 3.51
  • ARDT 0.00
  • MACD
  • BLTE 0.25
  • ARDT 0.00
  • Stochastic Oscillator
  • BLTE 42.55
  • ARDT 0.00

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About ARDT ARDENT HEALTH PARTNERS INC

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Share on Social Networks: